Loading graphs…
AI Summary
StalkFollowing a healthy Stage 2 advance, SCHL is holding above rising short-term EMAs despite mild overbought and exhaustion cues; a shallow pullback into the 9/21 EMA zone offers a favorable momentum entry for continuation.